市场调查报告书
商品编码
1380396
全球生物资讯学市场 2023-2030Global Bioinformatics Market 2023-2030 |
预计全球生物资讯学在预测期内(2023-2030年)将以12.3%的CAGR成长。生物资讯软体和工具被用作整合解决方案,为资料分析提供演算法和统计方法,并帮助整合下一代定序、基因组和蛋白质组结构、建模和三维药物设计等应用的资料管理和分析。生物资讯学在蛋白质、RNA和DNA等生物大分子三维结构预测中的日益采用是支持全球市场成长的关键因素。此外,研究人员现在不仅可以受益于试剂盒和服务来进行自己的 RNA 结构研究,还可以受益于细胞系和不同组织生成的资料库。因此,市场参与者也专注于引入 RNA 生物学并应用新发现来推进治疗研究,从而进一步促进市场成长。例如,2023 年 2 月,Eclipse Bioinnovations 是一家 RNA 基因组公司,致力于开发和商业化新型数据驱动的 RNA 技术,推出了 eSHAPE (TM) 技术套件,能够从 RNA 样本中探索 RNA 二级结构。
全球生物资讯学市场按产品、服务和应用进行细分。根据产品和服务,市场细分为知识管理工具、生物资讯学平台和生物资讯学服务。根据应用,市场细分为代谢组学、转录组学、蛋白质组学、基因组学和其他(化学资讯学)。在这些应用中,由于下一代定序等技术的发展,基因组学子领域预计将占据相当大的市场份额,这些技术使科学家能够研究构成人类基因组的基因序列,生物资讯学也至关重要以确保这些科学结果的可靠性。
在产品和服务中,生物资讯学平台细分市场预计将在全球生物资讯市场中占据相当大的份额。此细分市场的成长归因于电脑网路的影响力日益增强,电脑网路使生物资料的存取变得更加容易,并使得能够轻鬆开发用于分析的软体程式。研究人员可以使用任何浏览器轻鬆从现有资料堆迭中汇入檔案并存取数十个着名的生物资讯管道和资料视觉化工具,例如 CRISPResso2、RNA-Seq 和 AlphaFold。例如,2022 年 6 月,LatchBio 推出了一个端对端生物资讯平台,用于处理生物技术大资料以加速科学发现。它允许生物学家组织资料并运行流程,生物资讯学家上传新的工作流程,计算生物学家进行下游分析。
全球生物资讯市场根据地理位置进一步细分,包括北美(美国和加拿大)、欧洲(英国、义大利、西班牙、德国、法国和欧洲其他地区)、亚太地区(印度、中国、日本、韩国、亚洲其他地区)以及世界其他地区(中东和非洲以及拉丁美洲)。其中,由于亚太地区的成长,预计亚太地区将在全球市场中占据显着份额。生物资讯平台应用以及药物开发对更好工具的需求。主要市场参与者包括BGI Group、GENEWIZ, Inc.、Macrogen, Inc.、MedGenome Lab Pvt. Ltd.、Novogene 等。
在所有地区中,北美地区预计在预测期内将以相当大的CAGR成长。区域成长归因于对与分子生物学和基因组定序相关的新技术和创新技术的研发投资的增加,预计将推动区域市场的发展。例如,2022 年 6 月,加州生物技术研究新创公司 LatchBio 推出了一个端到端生物资讯学平台,可处理生物技术大资料以加速科学发现。
区域成长归因于先进技术的采用以及对药物发现和开发过程所需的更好生物资讯工具的需求增加。熟练且训练有素的生物资讯学家的存在以及该地区资讯技术部门的强劲发展预计将增强向已开发经济体提供外包服务的能力。预计政府的支持性政策也将在预测期内推动该地区的成长。主要市场参与者包括 Biomatters Inc.、DNAnexus.、Illumina Inc.、QIAGEN NV、Thermo Fisher Scientific Inc. 等。
Title: Global Bioinformatics Market Size, Share & Trends Analysis Report by Product & Services (Knowledge Management Tools, Bioinformatics Platforms and Bioinformatics Services), by Application (Metabolomics, Transcriptomics, Proteomics, Genomics and Others),Forecast Period (2023-2030).
The global bioinformatics is anticipated to grow at a CAGR of 12.3% during the Forecast Period (2023-2030). Bioinformatics software and tools are being used as integrated solutions that provide algorithms and statistical methodologies for data analysis and help integrate data management and analysis for applications such as next-generation sequencing, genomic and proteomic structuring, modelling, and three-dimensional drug designing. The growing adoption of Bioinformatics in the prediction of the three-dimensional structure of biological macromolecules such as proteins, RNA, and DNA is the key factor supporting the growth of the market globally. Additionally, Researchers can now not only benefit from kits and services to make their own studies on RNA structure but also from the databases generated from cell lines and different tissues. Hence, the market players are also focusing on introducing RNA biology and applying new discoveries to advance therapeutic research that further bolsters market growth. For instance, in February 2023, Eclipse Bioinnovations, an RNA genomics company developing and commercializing novel, data-driven technologies that interrogate RNA, launched its eSHAPE™ suite of technologies that enable exploration of RNA secondary structure from RNA samples.
The global bioinformatics market is segmented on the product & services and application. Based on the product & services, the market is sub-segmented into knowledge management tools, bioinformatics platforms and bioinformatics services. Based on the application, the market is sub-segmented into metabolomics, transcriptomics, proteomics, genomics and others (chemoinformatics). Among the applications, the genomics sub-segment is anticipated to hold a considerable share of the market owing to the rise in development of technologies like next-generation sequencing that allow scientists to study the genetic sequences that comprise the human genome, bioinformatics is also crucial to ensuring the reliability of these scientific results.
Among the products & services, the bioinformatics platforms sub-segment is expected to hold a considerable share of the global bioinformatics market. The segmental growth is attributed to the growing influence of computer networks that have allowed easy access to biological data and enabled the development of software programs for effortless analysis. Researchers can easily import files from existing data stacks and access dozens of prominent bioinformatics pipelines and data visualization tools, like CRISPResso2, RNA-Seq, and AlphaFold, using any browser. For instance, in June 2022, LatchBio launched an end-to-end bioinformatics platform for handling big biotech data to accelerate scientific discovery. It allows biologists to organize data and run processes, bioinformaticians to upload new workflows, and computational biologists to do downstream analysis.
The global Bioinformatics market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America. Among these, Asia Pacific is anticipated to hold a prominent share of the market across the globe, owing to an increase in bioinformatics platform applications and the need for better tools in drug development. The key market players include BGI Group, GENEWIZ, Inc., Macrogen, Inc., MedGenome Lab Pvt. Ltd., Novogene and others.
Among all regions, the North America regions is anticipated to grow at a considerable CAGR over the forecast period. Regional growth is attributed to increasing investments in the research & development of new and innovative technologies related to molecular biology and genome sequencing is expected to boost the regional market. For instance, in June 2022, LatchBio, California's biotechnology research startup, launched an end-to-end bioinformatics platform that handles big biotech data to accelerate scientific discovery.
Regional growth is attributed to adoption of advanced technology and increase in demand for better bioinformatics tools, that are required in drug discovery and development process. The presence of skilled and trained bioinformaticians and the expected strong development of the region's IT sector are anticipated to enhance the capability of providing outsourcing services to developed economies. Supportive government policies are also expected to drive the growth of this region over the forecast period. The key market player include Biomatters Inc., DNAnexus., Illumina Inc., QIAGEN N.V., Thermo Fisher Scientific Inc. and others.
The major companies serving the bioinformatics market include: Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche AG, Illumina Inc., Qiagen N.V., Thermo Fisher Scientific Inc., and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in January 2023, PacBio, a developer of highly accurate sequencing solutions, collaborated with the University of Tokyo, Graduate School of Medicine to study the use of long-read sequencing and novel bioinformatics methods in the hopes of better understanding the genetic causes of certain rare diseases in individuals.